Literature DB >> 17302923

Resistance phenotypes conferred by macrolide phosphotransferases.

Olivier Chesneau1, Krassimira Tsvetkova, Patrice Courvalin.   

Abstract

This study aims to compare the resistance phenotypes conferred by various genes encoding enzymes that phosphorylate erythromycin. The mph genes were cloned into Escherichia coli AG100A susceptible to macrolides and ketolides following disruption of the AcrAB pump. An 882 bp sequence containing a premature stop codon, homologous to the three other previously described mph genes and present widely among Enterobacteriaceae, was found to confer resistance to erythromycin by phosphorylation. The mph(C) gene, as reported for mph(B), also conferred resistance to spiramycin. The mph(A) gene was unique in conferring resistance to azithromycin. The four investigated genes conferred resistance to telithromycin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302923     DOI: 10.1111/j.1574-6968.2007.00643.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

Review 1.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

2.  Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene.

Authors:  Adeline Achard; Véronique Guérin-Faublée; Vianney Pichereau; Corinne Villers; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

3.  Antibiotic resistance is prevalent in an isolated cave microbiome.

Authors:  Kirandeep Bhullar; Nicholas Waglechner; Andrew Pawlowski; Kalinka Koteva; Eric D Banks; Michael D Johnston; Hazel A Barton; Gerard D Wright
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 4.  Antibiotics and bacterial resistance in the 21st century.

Authors:  Richard J Fair; Yitzhak Tor
Journal:  Perspect Medicin Chem       Date:  2014-08-28

5.  The evolution of substrate discrimination in macrolide antibiotic resistance enzymes.

Authors:  Andrew C Pawlowski; Peter J Stogios; Kalinka Koteva; Tatiana Skarina; Elena Evdokimova; Alexei Savchenko; Gerard D Wright
Journal:  Nat Commun       Date:  2018-01-09       Impact factor: 14.919

Review 6.  Look and Outlook on Enzyme-Mediated Macrolide Resistance.

Authors:  Tolou Golkar; Michał Zieliński; Albert M Berghuis
Journal:  Front Microbiol       Date:  2018-08-20       Impact factor: 5.640

7.  Azithromycin resistance levels and mechanisms in Escherichia coli.

Authors:  Cláudia Gomes; Lidia Ruiz-Roldán; Judit Mateu; Theresa J Ochoa; Joaquim Ruiz
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

8.  Tracking Antimicrobial Resistance Determinants in Diarrheal Pathogens: A Cross-Institutional Pilot Study.

Authors:  Chris R Taitt; Tomasz A Leski; Michael G Prouty; Gavin W Ford; Vireak Heang; Brent L House; Samuel Y Levin; Jennifer A Curry; Adel Mansour; Hanan El Mohammady; Momtaz Wasfy; Drake Hamilton Tilley; Michael J Gregory; Matthew R Kasper; James Regeimbal; Paul Rios; Guillermo Pimentel; Brook A Danboise; Christine E Hulseberg; Elizabeth A Odundo; Abigael N Ombogo; Erick K Cheruiyot; Cliff O Philip; Gary J Vora
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

9.  Genome-Wide Analysis of Staphylococcus aureus Sequence Type 72 Isolates Provides Insights Into Resistance Against Antimicrobial Agents and Virulence Potential.

Authors:  Nayab Batool; Amen Shamim; Akhilesh Kumar Chaurasia; Kyeong Kyu Kim
Journal:  Front Microbiol       Date:  2021-01-20       Impact factor: 5.640

10.  The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis.

Authors:  Marek Juda; Beata Chudzik-Rzad; Anna Malm
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.